3Vestbo J, Hurd SS, Agustf AG, et al. Global strategy for the diag- nosis, management, and prevention of chronic obstructive pulmo- nary disease: GOLD executive summary [ J ]. Am J Respir Crit Care Med, 2013,187(4) :347-365.
4Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations [J]. Crit Care Med, 2008,36(3) :941-952.
6Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract nfections in "reallife" : an international, multicenter poststudy survey (ProREAL) [J]. Arch Intern ned, 2012,172(9):715-722.
7Jaccard-Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD : a randomized, controlled trial comparing Procalcitonin-guidance with standard therapy [ J ]. Chest, 2007.131 ( 1) :9-19.
9Vestbo J,Hurd S S,AgustíA G,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2013,187(4):347.
10Wang H,Gu X,Weng Y,et al.Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease[J].BMC Pulm Med,2015,15(1):94.
